OSRH supply chain intelligence for OSR Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
OSR Holdings, Inc. (OSRH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| VAXIMM-AG | VAXIMM-AG | 92% | Vaximm agreed to sell, and the Company agreed to purchase, free and clear of all encumbrances, all of Vaximm's right, title and interest in and to the VXM01 intellectual property family |
| BCM-EUROPE-AG | BCM-EUROPE-AG | 90% | The Global Exclusive License Agreement entered into among the Company, Vaximm AG, and BCM Europe AG. |
| OSR-HOLDINGS-CO-LTD | OSR-HOLDINGS-CO-LTD | 90% | Mr. Kim, age 36, most recently served as a Senior Analyst at OSR Holdings Co., Ltd., a subsidiary of the Company, from 2020 to 2025, where he supported the Company and its subsidiaries’ cross-border … |
| WOORI-IO-CO-LTD | WOORI-IO-CO-LTD | 90% | The Parent acquired subsidiary in January 26, 2026 and accounted for the acquisitions at January 1, 2026, which is deemed the acquisition date. |
| DUKSUNG-CO-LTD | DUKSUNG-CO-LTD | 80% | The Group has a loan agreement with Duksung Co., Ltd and as of March 31, 2026, the outstanding balance was $ 650,000 |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BCM-EUROPE-AG | BCM-EUROPE-AG | 92% | BCME is obligated to pay the Company milestone payments of up to $815,000,000 in the aggregate upon the achievement of specified clinical, regulatory, and commercial milestones. |
| SALES-GROSS-PROFIT-OSR-HOLDINGS | SALES-GROSS-PROFIT-OSR-HOLDINGS | 85% | 28,888,361 ) -16,995,683 143 % 106 Net Sales, Cost of Sales, Gross Profit OSR Holdings’ net sales, cost of sales, and gross profit are primarily derived from RMC, its subsidiary engaged in the distri… |
| BELLEVUE-CAPITAL-MANAGEMENT-LLC | BELLEVUE-CAPITAL-MANAGEMENT-LLC | 62% | . Accordingly, management expects this consignment-based model to enhance the stability of gross profit margins in future periods. Selling, General and Administrative Expenses For the three months en… |
| BELLEVUE-GLOBAL-LIFE-SCIENCES-INVESTORS-LLC | BELLEVUE-GLOBAL-LIFE-SCIENCES-INVESTORS-LLC | 62% | average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in colu… |
| BENJAMIN-SECURITIES-INC | BENJAMIN-SECURITIES-INC | 62% | may be the target of securities class action and derivative lawsuits which could result in substantial costs. Our share price may be volatile and, in the past, companies that have experienced volatil… |
| CHARDAN-CAPITAL-MARKETS-LLC | CHARDAN-CAPITAL-MARKETS-LLC | 62% | may be the target of securities class action and derivative lawsuits which could result in substantial costs. Our share price may be volatile and, in the past, companies that have experienced volatil… |
| CO-LTD | CO-LTD | 62% | n Co., Ltd. (“Darnatein”) 4,506,702 100.00 % Biotech (drug development) OSR Holdings, Inc. (“OSRI”) (*1) 2,687 100.00 % SPAC Key financial information of the subsidiaries at December 31, 2025 are as … |
| DONOHOE-ADVISORY-ASSOCIATES-LLC | DONOHOE-ADVISORY-ASSOCIATES-LLC | 62% | Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of operations should be read… |
| DUKSUNG-CO-LTD | DUKSUNG-CO-LTD | 62% | ows: For the year ended December 31, 2025 Beginning Business combination Impairment loss Effects of changes in exchange rate Ending Goodwill $ 24,354,066 $ - $ - $ 595,740 $ 24,949,806 For the year e… |
| EXPENSE-OSR-HOLDINGS | EXPENSE-OSR-HOLDINGS | 62% | . Accordingly, management expects this consignment-based model to enhance the stability of gross profit margins in future periods. Selling, General and Administrative Expenses For the three months en… |
| KOREA-TECHNOLOGY-FINANCE-CORPORATION | KOREA-TECHNOLOGY-FINANCE-CORPORATION | 62% | ning Business combination Impairment loss Effects of changes in exchange rate Ending Goodwill $ 24,949,806 $ 6,405,124 $ - $ ( 1,626,379 ) $ 29,728,552 For the three-months ended March 31, 2025 Begin… |
| LEASES-THE-GROUP | LEASES-THE-GROUP | 62% | n Co., Ltd. (“Darnatein”) 4,506,702 100.00 % Biotech (drug development) OSR Holdings, Inc. (“OSRI”) (*1) 2,687 100.00 % SPAC Key financial information of the subsidiaries at December 31, 2025 are as … |
| OSR-HOLDINGS | OSR-HOLDINGS | 62% | . Accordingly, management expects this consignment-based model to enhance the stability of gross profit margins in future periods. Selling, General and Administrative Expenses For the three months en… |
| OSR-HOLDINGS-CO-LTD | OSR-HOLDINGS-CO-LTD | 62% | er 31, 2025. The Parent has entered into various contractual commitments related to the acquisition of VAXIMM including a future financial obligation of CHF 28,898 underlying as of March 31, 2026. Me… |
| OVERVIEW-OSR-HOLDINGS-INC | OVERVIEW-OSR-HOLDINGS-INC | 62% | Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of operations should be read… |
| R-D-EXPENSES-OSR-HOLDINGS | R-D-EXPENSES-OSR-HOLDINGS | 62% | . Accordingly, management expects this consignment-based model to enhance the stability of gross profit margins in future periods. Selling, General and Administrative Expenses For the three months en… |
| TACTION-CO-LTD | TACTION-CO-LTD | 62% | rest income $ 63,883 $ 21,294 Foreign exchange gains 48,472 37,419 Gains on foreign currency translation 46,018 38,416 Interest expense ( 506,196 ) ( 51,335 ) Losses on foreign currrency transaction … |
| VAXIMM-AG | VAXIMM-AG | 62% | n Co., Ltd. (“Darnatein”) 4,506,702 100.00 % Biotech (drug development) OSR Holdings, Inc. (“OSRI”) (*1) 2,687 100.00 % SPAC Key financial information of the subsidiaries at December 31, 2025 are as … |
| WHITE-LION-CAPITAL-LLC | WHITE-LION-CAPITAL-LLC | 62% | merger-related expenses were one-time in nature and did not involve cash outflows. Loss Before Income Taxes For the year ended December 31, 2025, OSR Holdings’ loss before income taxes increased by $… |
| WOORI-IO-CO-LTD | WOORI-IO-CO-LTD | 62% | as to the insurance coverage and reimbursement status of any products for which we may obtain regulatory approval. In the United States, sales of any products for which we may receive regulatory appr… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| OSRH-DEBT-11604 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| OSRH-DEBT-11603 | Warrants outstanding: 1236527 | 90% | xbrl warrant detail from xbrl 2023-12-31. |
| OSRH-DEBT | Debt stack $5.0M | 90% | Market cache reports total debt of $5.0M. |